- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
Détention brevets de la classe C07K 7/08
Brevets de cette classe: 6870
Historique des publications depuis 10 ans
|
532
|
513
|
516
|
573
|
584
|
540
|
530
|
455
|
405
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1170 |
255 |
| The Regents of the University of California | 19503 |
108 |
| Bicyclerd Limited | 138 |
72 |
| Centre National de La Recherche Scientifique | 10091 |
69 |
| Protagonist Therapeutics, Inc. | 142 |
59 |
| Caregen Co., Ltd. | 276 |
51 |
| Bicycletx Limited | 167 |
48 |
| Toagosei Co., Ltd. | 951 |
43 |
| Bristol-myers Squibb Company | 4865 |
41 |
| GemVax & Kael Co., Ltd. | 91 |
41 |
| Bausch Health Ireland Limited | 774 |
36 |
| Agency for Science, Technology and Research | 3562 |
34 |
| The University of British Columbia | 1468 |
34 |
| Kagoshima University | 297 |
32 |
| Seoul National University R&db Foundation | 3302 |
32 |
| The Trustees of the University of Pennsylvania | 4254 |
31 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
30 |
| Takeda Pharmaceutical Company Limited | 2945 |
28 |
| Oncotherapy Science, Inc. | 297 |
28 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2062 |
26 |
| Autres propriétaires | 5772 |